New promise of cancer immunotherapy to treat rare lymphoma – Science Daily
Science Daily |
New promise of cancer immunotherapy to treat rare lymphoma
Science Daily Three case reports published in the New England Journal of Medicine demonstrate the promise of cancer immunotherapy in gray zone lymphoma, a rare subtype that mixes characteristics of Hodgkin and Non-Hodgkin forms of the disease. In one case from … |
